NephSpace
by Wael Hussein
Weekly · Nov 16: How Low to Go on Blood Pressure, People Over…
About this podcast
NephSpace makes new kidney research easy and fun to follow.
Every week, Dr. Wael Hussein, an academic nephrologist in Memphis, picks the most interesting new papers and news in nephrology, and two hosts talk them through: the story, the key numbers, why it matters, and an honest take on what the study does and doesn't prove.
Weekly episodes cover that week's picks from the kidney journals, the big general journals and the specialty news. Deep Dives follow one question further: two treatments racing for the same goal, a trial worth arguing about, a case that a new paper answers.
Made for nephrologists and nephrology fellows.
Physician-led, AI-assisted. The hosts are AI voices. Disclosures are in every episode's notes.
For education and information only, not medical advice. Please talk to your own physician or care team about your health. Full disclaimer: nephspace.com/disclaimer. Views are the creator's own and not those of his employer. Papers are summarized in our own words, with links to the originals.
nephspace.com · [email protected]
Episodes
- Weekly · Nov 16: How Low to Go on Blood Pressure, People Over Pop-ups, the Fistula and the Heart, and the Silent Brain · 22 min · Episode 11This week is all about pressure. Two new trials from Brazil tested a systolic target under 120, one in type 2 diabetes and one after a stroke: one group came out ahead, and in…
- Weekly · Nov 9: Dialysis or Not for the Frail Older Patient, Reading Frailty at the Chair, and How to Have the Conversation · 23 min · Episode 10One subject this week, three papers, in the order a clinician needs them. The first randomized trial ever run on preparing a frail older patient for dialysis versus preparing…
- Weekly · Nov 2: SGLT2 Inhibitors and Hemoglobin, Avacopan Revoked in Europe, PD Catheter Timing and Sodium on CRRT · 22 min · Episode 9A rising hemoglobin on an SGLT2 inhibitor: bonus, or warning sign? A meta-analysis of 85 randomized trials in JAMA puts the average rise at about 0.6 g/dL and calls its clinical…
- Weekly · Oct 26: IgA Nephropathy's Turning Point, Access in the Very Old, SGLT2 in ADPKD and the Federal Kidney Plan · 22 min · Episode 7It was ASN Kidney Week, and IgA nephropathy took center stage: four phase 3 trials in the New England Journal of Medicine and an FDA accelerated approval for ravulizumab. Two…
- Weekly · Oct 20: Intermittent or Continuous Dialysis in the ICU, Fluid Creep, Deprescribing and the Dialysis Bike · 22 min · Episode 6For years, most of us thought it didn't matter whether critically ill patients started on intermittent hemodialysis or continuous therapy. In the ICRAKI trial, starting on…
- Weekly · Oct 12: Fluids or Pressors, ICU Bicarbonate and What's Holding Back PD · 19 min · Episode 5Three reflexes worth rethinking. In septic shock in the emergency department, stopping the fluid and starting the vasopressor early showed no difference in days alive and out of…
- Deep Dive · Two Desks: Should AI Write the Fellow's Notes? · 18 min · Episode 4A 60-page referral, nine years of creatinine, and an AI summary waiting on two desks: the attending's and the first-year fellow's. A Kidney360 perspective says to hand drafting…
- Weekly · Oct 5: Drugs for CKD and Dialysis, the Heart on Dialysis, and a Camera for Fistulas · 25 min · Episode 3A new lipid guideline makes reduced kidney function a reason for a statin; in 2024, before it arrived, most patients for whom kidney function is now the reason had no statin…
- Trailer · Why NephSpace · 2 minI want to keep up with nephrology. But the new papers sit behind logins and scattered across sites, so I end up doomscrolling instead. NephSpace brings the week's kidney research…
- Deep Dive · Two Roads: Hemodiafiltration or Medium Cutoff Dialyzers? · 20 min · Episode 2Two dialysis patients, same city, same week. One gets a new machine that filters and replaces more than 20 liters every session. The other gets the same old machine with a new…
- Weekly · Oct 2: The Middle-Molecule Race, a Dipstick Adherence Check, and AI for Fellows · 31 min · Episode 1Two ways to clear more middle molecules arrive in US dialysis units at once. A urine dipstick can show whether patients are taking their SGLT2 inhibitor. Two papers disagree…








